Citeline Commercial

Accelerate your path from pipeline to patient: https://ow.ly/Rweg50TGhkq. NorstellaLinQ connects 74 billion data points, paving the way for breakthroughs in drug development and commercialization: https://ow.ly/Rweg50TGhkq. • Insights of 500,000 investigators • Tens of thousands of clinical trials across 185 countries • Hundreds of brand launches • Tens of thousands of forecasts Get closer to the patient than ever before. Learn more about NorstellaLinQ from Norstella, the parent company of Citeline: https://ow.ly/Rweg50TGhkq.

Breaking News! 📰 Major announcements and exclusive interviews coming your way from #JPM2025. Sign up for daily updates! https://ow.ly/Pszq50UoxSX. _____ Follow Citeline Commercial for your comprehensive industry news and strategic insights into the global life sciences and biotechnology markets.

Start your free Pink Sheet trial today! When it comes to pharma regulation, policy, HTA, market access, news, and more, Citeline's dedicated expert journalists keep you in the know. Citeline Citeline Commercial Citeline Regulatory #PinkSheet #RegulatoryAffairs

US biosimilar competition to Stelara is waiting in the wings from the very start of 2025. But with seven ustekinumab rivals already approved by the FDA and set to launch, how will things shake out in such a crowded market? Citeline Commercial's Generics Bulletin looks at the contenders. https://lnkd.in/eKDzatpF

Your inside track to #JPM2025! https://ow.ly/qSoT50Uu8WV Need the highlights? We’ve got you covered. Our daily updates deliver the trends, takeaways, and expert insights shaping the future of biopharma—straight to your inbox. Don’t miss out!

Curious about the latest trends shaping the future of oncology? Unlock key biotech insights on oncology R&D trends: https://ow.ly/Vp6F50Uu8C8 with ICON plc Biotech. Access this short video to explore the key therapeutic approaches in development, the biggest challenges in clinical trials, where AI/ML is making the biggest impact, and a future outlook on the trends driving innovation. Access it here: https://ow.ly/Vp6F50Uu8C8.

📣🎙️Podcast Alert! The Importance of Site Networks in Accelerating End-to-End Drug Development: https://ow.ly/4gTS50UsYj1. Is working with a site network the key to faster, more efficient drug development? Listen now to explore the benefits of utilizing site networks over individual clinical trial sites. Discover the advantages of site networks in ensuring scalability, data integrity, patient access, regulatory compliance, and more. Listen to the podcast now in partnership with CenExel: https://ow.ly/4gTS50UsYj1.

Medtech Insight's Marion W. talked to two leaders at the Alzheimer's Drug Discovery Foundation at BIO 2024 about the role of biomarkers and digital tools, building on recent advancements in Alzheimer’s research. Read it now: https://ow.ly/qAse50Sy53V.

In this week's episode of the Citeline Commercial #podcast: a snapshot of the atopic dermatitis market; Bill Burns profile; GSK’s Blenrep makes a comeback; CML results at ASH; and what’s driving optimism on India. #pharma #biotech On your usual platforms or free access below. Norstella 

In front of our usual paywall, Citeline Commercial's Generics Bulletin brings you our final podcast of the year, in which I talk to GB writers Dean Rudge, Urte Fultinaviciute and Adam Z. about some of our highlights of the past twelve months. I hope all of our listeners enjoy celebrating the end of 2024 - and we look forward to bringing you more podcasts in 2025! https://lnkd.in/euvMyRpR